Stryker Other — Net Sales increased by 10.9% to $406.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 59.8%, from $254.00M to $406.00M. Over 3 years (FY 2021 to FY 2024), Other — Net Sales shows a downward trend with a -4.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration or expansion of niche product lines, while a decrease may suggest market saturation or a strategic shift away from these specific product categories.
This metric represents the total revenue generated from the 'Other' segment, which encompasses specialized medical produ...
Peers in the medical device industry typically report similar 'Other' or 'Miscellaneous' segments to capture revenue from non-core, specialized, or emerging product lines that do not meet the threshold for separate reporting.
syk_segment_other_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $254.00M | $246.00M | $906.00M | $332.00M | $382.00M | $366.00M | $474.00M | $188.00M | $238.00M | $260.00M | $332.00M | $266.00M | $272.00M | $254.00M | $632.00M | $324.00M | $366.00M | $406.00M |
| QoQ Change | — | -3.1% | +268.3% | -63.4% | +15.1% | -4.2% | +29.5% | -60.3% | +26.6% | +9.2% | +27.7% | -19.9% | +2.3% | -6.6% | +148.8% | -48.7% | +13.0% | +10.9% |
| YoY Change | — | — | — | — | +50.4% | +48.8% | -47.7% | -43.4% | -37.7% | -29.0% | -30.0% | +41.5% | +14.3% | -2.3% | +90.4% | +21.8% | +34.6% | +59.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.